As of November 13, 2017, the Department of Transportation (DOT) published a final rule in the Federal Register (82 FR 52229).
The rule, among other items, added four semi-synthetic opioids :
It also added methylenedioxyamphetamine (MDA) as an initial test analyte and removed the testing for methylenedioxyethylamphetaime (MDEA).
The final rule will become effective January 1, 2018. Along with the current analytes, employers will now also be tested for the semi-synthetic opioids listed above. Common names for these opioids can include:
Additionally, as employers, you will no longer be required to submit blind specimens to laboratories.
The final ruling can be viewed through ODAPC’s website here. One Source will continue to update you as more information is provided. Your DOT drug testing services will be updated in accordance to the new ruling. We will provide you with more information concerning the transition, once it becomes available.
If you have any questions, please contact the Client Relations Department at email@example.com or via phone at 1.800.608.3645 (Option 1).